ABSTRACT
On October 7, 2003, the U.S. Patent Office issued Patent No.: US 6,630,507 B1 for cannabinoids as antioxidants and neuroprotectants [1]. Booz elaborates on the use of cannabidiol (CBD) for reducing inflammation due to oxidative stress in pain, diabetic complications, hypertension, ischemia reperfusion injury, depression, neurodegenerative diseases, obesity, and atherosclerosis [2].
